DM
VIGL

Deerfield Management’s Vigil Neuroscience VIGL Stock Holding History

Deerfield Management’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-980,311
Closed -$3.34M – 568
2024
Q1 		$3.34M Sell
980,311
-193,212
-16% -$603K 0.06% 76
2023
Q4 		$3.97M Sell
1,173,523
-653,877
-36% -$3.36M 0.07% 60
2023
Q3 		$9.85M Sell
1,827,400
-224,610
-11% -$1.55M 0.22% 58
2023
Q2 		$19.3M Hold
2,052,010
– – 0.41% 49
2023
Q1 		$20.1M Hold
2,052,010
– – 0.45% 53
2022
Q4 		$25.7M Sell
2,052,010
-2,784
-0.1% -$34.2K 0.53% 54
2022
Q3 		$18M Buy
+2,054,794
New +$15.1M 0.36% 65

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Deerfield Management's VIGL Position: Q2 2024 in Review

Deerfield Management sold out of Vigil Neuroscience (VIGL) in Q2 2024, closing a stake of 980,311 shares — an estimated $3.34M sold.

Deerfield Management first reported a position in VIGL in Q3 2022 and held it in 7 quarters. The position peaked at $25.7M in Q4 2022. 58 funds tracked by Wall St. Rank hold VIGL as of Q2 2024.

  • Deerfield Management reported no remaining Vigil Neuroscience position as of Q2 2024 after selling out during the quarter.
  • Deerfield Management sold 980,311 Vigil Neuroscience shares in Q2 2024, an estimated $3.34M.
  • Deerfield Management first reported a position in Vigil Neuroscience in Q3 2022 and held it in 7 quarters.
  • Deerfield Management's Vigil Neuroscience position peaked at $25.7M in Q4 2022.
  • 58 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.